Nasdaq

New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients

LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ: CDXC) today announced results from the study “Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19” were published ...
Nasdaq

New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function

A new clinical study published in Cell Press Sneak Peek finds nutritional protocol including nicotinamide riboside (NR) significantly decreases liver fat, improves liver function The results of the ...
TechCrunch

Heali’s app provides personalized nutrition guide to using food as medicine

Taking control of your health can be complicated, especially when you don’t know where to start or are presented with millions of options. Enter Heali, a new startup launching out of stealth with a ...
The Manila Times

CNI (Hong Kong) Yuanqizhi International Limited Launches Father's Day Family Wellness Package Combining In-Home Pain Management and Nutritional Solutions

Yuanqizhi International Limited today announced the launch of its comprehensive "Filial Piety" Family Wellness Program, a ...
Business Wire

New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function

LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ: CDXC) today announced results from the study “Combined Metabolic Cofactor Supplementation Reduces Liver Fat in Nonalcoholic Fatty Liver Disease” ...
Odessa American

New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function

ChromaDex Corp. (NASDAQ: CDXC) today announced results from the study “Combined Metabolic Cofactor Supplementation Reduces Liver Fat in Nonalcoholic Fatty Liver Disease” were published on Cell Press ...